Enhanced oxidizability of ubiquinol and α-tocopherol during lovastatin treatment

FEBS Letters

Volumn 410, Issue 2-3, 1997, Pages 254-258

  Palomäki, Ari ^a   Malminiemi, Kimmo ^b   Metsä Ketelä, Timo ^c  

^a KANTA HÄME CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Antioxidant; LDL cholesterol; Lovastatin; Oxidation; Ubiquinol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; UBIQUINONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, LDL; COPPER; CORONARY DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MIDDLE AGED; OXIDATION-REDUCTION; TRIGLYCERIDES; UBIQUINONE; VITAMIN E;

EID: 0343145692     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)00609-1     Document Type: Article

References (38)

1. Goldstein J.L., Brown M.S. Nature (London). 343:1990;425-430.
2. Åberg F., Appelkvist E.-L., Dallner G., Ernster L. Arch. Biochem. Biophys. 295:1992;230-234.
3. Hanaki Y., Sugiyama S., Ozawa T., Ohno M. Clin. Invest. 71:1993;S112-S115.
4. Mohr D., Bowry V.W., Stocker R. Biochim. Biophys. Acta. 1126:1992;247-254.
5. Maquire J.J., Kagan V., Ackrell B.A.C., Serbinova E., Packer L. Arch. Biochem. Biophys. 292:1992;47-53.
6. Kontush A., Hübner C., Finckh B., Kohlschütter A., Beisiegel U. Biochim. Biophys. Acta. 1258:1995;177-187.
7. Tribble D.L., Van den Berg J.J.M., Motchnik P.A., Ames B.N., Lewis D.M., Chait A., Krauss R.M. Proc. Natl. Acad. Sci. USA. 91:1994;1183-1187.
8. EC Note for Guidance (1990) Good Clinical Practice for Trials on Medicinal Products in the European Community. III/3976/88-EN.
9. Wieland H., Seidel D. J. Lipid Res. 24:1983;904-909.
10. Niki E., Yamamoto Y., Komuro E., Sato K. Am. J. Clin. Nutr. 53:1991;201S-205S.
11. Lang J.K., Gohil K., Packer L. Anal. Biochem. 157:1986;106-116.
12. Peterson G.L. Methods Enzymol. 91:1983;95-119.
13. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Free Radic. Res. Commun. 6:1989;67-75.
14. Fiske C.H., SubbaRow Y. J. Biol. Chem. 66:1925;375-400.
15. Itaya K., Ui M. Clin. Chim. Acta. 14:1966;361-366.
16. Lehtimäki T., Moilanen T., Viikari J., Åkerblom H., Ehnholm C., Rönnemaa T., Marniemi J., Dahlen G., Nikkari T. J. Lipid Res. 31:1990;487-495.
17. Superko H.R., Krauss R.M. Circulation. 90:1994;1056-1069.
18. Scandinavian Simvastatin Survival Study Group (1994) Lancet 344, 1383-1389.
19. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., Macfarlane, P.W., McKillop, J.H., Packard, C.J. and West of Scotland Coronary Prevention Study Group (1995) N. Engl. J. Med. 333, 1301-1307.
20. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., et al. N. Engl. J. Med. 335:1996;1001-1009.
21. Tikkanen, M.J., Helve, E., Jäättelä, A., Kaarsalo, E., Lehtonen, A., Malbecq, W., Oksa, H., Pääkkönen, P., Salmi, J., Veharanta, T., Viikari, J., Äärynen, M. and Finnish Lovastatin Study Group (1988) Am. J. Cardiol. 62, 35-43.
22. Bargossi A.M., Battino M., Gaddi A., Fiorella P.L., Grossi G., Barozzi G., Di Giulio R., Descovich G., Sassi S., Genova M.L., Lenaz G. Int. J. Clin. Lab. Res. 24:1994;171-176.
23. Chirlanda G., Oradei A., Manto A., Lippa S., Uccioli L., Caputo S., Greco A.V., Littarru G.P. J. Clin. Pharmacol. 33:1993;226-229.
24. Watts G.F., Castelluccio C., Rice-Evans C., Taub N.A., Baum H., Quinn P.J. J. Clin. Pathol. 46:1993;1055-1057.
25. Laaksonen R., Ojala J.-P., Tikkanen M.J., Himberg J.J. Eur. J. Clin. Pharmacol. 46:1994;313-317.
26. Appelkvist E.L., Edlund C., Löw P., Schedin S., Kaln A., Dallner G. Clin. Invest. 71:1993;S97-S102.
27. Halliwell B., Hu M.-L., Louie S., Duvall T.R., Tarkington B.K., Motchnik P., Cross C.E. FEBS Lett. 313:1992;62-66.
28. Neuzil J., Stocker R. J. Biol. Chem. 269:1994;16712-16719.
29. Wu T.-W., Fung K.-P., Yang C.-C. Pharmacol. Lett. 54:1994;477-481.
30. Chirico S., Smith C., Marchant C., Mitchinson M.J., Halliwell B. Free Radic. Res. Commun. 19:1993;51-57.
31. Giessauf A., Steiner E., Esterbauer H. Biochim. Biophys. Acta. 1256:1995;221-232.
32. Blankenhorn, D.H., Azen, S.P., Kramsch, D.M., Mack, W.J., Cashin-Hemphill, L., Nodis, H.N., DeBoer, L.W.V., Mahrer, P.R., Masteller, M.J., Vailas, L.I., Alaupovic, P., Hirsch, L.J. and MARS Resarch Group (1993) Ann. Intern. Med. 119, 969-976.
33. Hunninghake D.B., Stein E.A., Dujovne C.A., Harris W.S., Feldman E.B., Miller V.T., Tobert J.A., Laskarzewski P.M., Quiter E., Held J., Taylor A.M., Hopper S., Leonard S.B., Brewer B.K. N. Engl. J. Med. 328:1993;1213-1219.
34. Stocker R., Bowry V.W., Frei B. Proc. Natl. Acad. Sci. USA. 88:1991;1646-1650.
35. Gieseg S.P., Esterbauer H. FEBS Lett. 343:1994;188-194.
36. Walzem R.L., Watkins S., Frankel E.N., Hansen R.J., German J.B. Proc. Natl. Acad. Sci. USA. 92:1995;7460-7464.
37. Bui M.N., Caulfield M.T., Katz P.C. III, Richard O., Rackley C.E. J. Am. Coll. Cardiol. 27:1996;413A.
38. Laaksonen R., Jokelainen K., Laakso J., Sahi T., Härkönen M., Tikkanen M.J., Himberg J.J. Am. J. Cardiol. 77:1996;851-854.